The Australian Centre for Hepatitis Virology (ACHV) is an incorporated body of biomedical scientists throughout Australia with the common interest of promoting and disseminating research into all aspects of the hepatitis and related viruses.
ACHV Workshops
29 November - 2 December 2023
The 18th ACH4 annual scientific workshop was held in conjunction [...]
25-27th May 2022
The 17th ACH2 annual scientific workshop was held at the [...]
2 - 4 June 2021
The 16th ACH2 annual scientific workshop was held at Peppers [...]
Tweets
In HBeAg-negative CHB stopping NA therapy, low end-of-treatment HBsAg–anti-HBs immune complexes predicted hepatitis flare. HBsAg-IC levels rose dynamically with ALT during flares, linking humoral immunity to flare risk and HBsAg decline #HBV
In an Asian HIV–HBV cohort starting HBV-active ART, 22% lost HBsAg within 2 years—most by 12 months. Loss was linked to higher ALT, lower liver stiffness, low baseline qHBsAg, and TAF-based regimens, highlighting early ART as a window toward HBV cure #HBV
Why do some people repeatedly clear HCV? This study links it to stem-like, self-renewing CD8⁺ memory T cells with strong recall capacity. #HCV
In early HCV infection, CD8 T cells without neutralizing antibodies drive viral escape, lowering fitness. Later, compensatory mutations restore fitness, enabling chronic infection. Early combined T & B cell responses are key for clearance. #HCV #virology